Kopp Family Office, LLC Portfolio Holdings

Kopp Family Office, LLC

$158 Million
Q4 2024

Kopp Family Office, LLC has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $158 Million distributed in 21 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vanguard Ftse Developed Market with a value of $29.3M, Vanguard Ftse Emerging Mkts Et with a value of $17.5M, Vericel Corp with a value of $14.8M, Neogenomics Inc with a value of $13.7M, and Five9, Inc. with a value of $13.5M.

Examining the 13F form we can see an increase of $787K in the current position value, from $157M to 158M.

Kopp Family Office, LLC is based out at Bloomington, MN

Below you can find more details about Kopp Family Office, LLC portfolio as well as his latest detailed transactions.

Portfolio value $158 Million

ETFs: $74.1 Million

Technology: $43.8 Million

Healthcare: $40 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
NEO Neogenomics Inc Healthcare	$1.28B	$13.7 Million 8.65% of portfolio	828,575	Q4 2024 Reduced 10.62%
VRDN Viridian Therapeutics, Inc.\De Healthcare	$608M	$3.94 Million 2.5% of portfolio	205,407	Q4 2024 Reduced 0.16%

Summary

Portfolio
No. of Stocks 21
Current Value $158 Million
Prior Value $157 Million
Filing
Period Q4 2024
Filing Date February 13, 2025
Form Type 13F-HR
Activity in Q4 2024
New Purchases 0 stocks
Additional Purchases 5 stocks
Sold out of 0 stocks
Reduced holdings in 12 stocks

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kopp Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kopp Family Office, LLC with notifications on news.

Account

Kopp Family Office, LLC Portfolio Holdings